GELS

Gelteq Limited (NASDAQ:GELS) is an Australian pharmaceutical technology company founded in 2017 and headquartered in Caulfield, Australia. The company specializes in developing and commercializing innovative gel-based delivery systems for pharmaceutical and consumer health products across both human and animal applications. Since its incorporation, Gelteq has positioned itself as a white-label solutions provider in the drug delivery space, focusing on creating proprietary gel formulations that can enhance the effectiveness and user experience of various therapeutic and wellness products.